{"id":"https://genegraph.clinicalgenome.org/r/5e05d6c8-62e2-4496-bbec-2d499c924d39v1.1","type":"EvidenceStrengthAssertion","dc:description":"ARFGEF2 was first reported in connection to autosomal recessive periventricular heterotopia with microcephaly in 2004 (Sheen et al., 2004 PMID:14647276). Common phenotypes for individuals with ARFGEF2 - periventricular heterotopia with microcephaly include progressive microcephaly, severe GDD/ID, hypotonia, spasticity, hyperkinetic movement disorder, epilepsy, failure to thrive, cardiomyopathy, corpus callosum thinning, and putamen T2 hyperintensity/atrophy. \n\nNine unique variants of different types (3 frameshift, 2 missense, 2 nonsense, 1 canonical splice site) reported in seven probands have been included in this curation (PMID:14647276, 19384555, 23755938, 23812912, 25160555, 26126837). The presumed mechanism is loss of function. The maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is further supported by functional alteration, protein interaction, and expression data (PMID:16320251, 14647276). \n\nIn summary, there is definitive evidence to support the relationship between ARFGEF2 and autosomal recessive periventricular heterotopia with microcephaly. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Brain Malformations expert panel on 09/12/2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5e05d6c8-62e2-4496-bbec-2d499c924d39","GCISnapshot":"https://genegraph.clinicalgenome.org/r/814507e0-e6cd-4bce-a4c6-4d1caa61cfc3","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:classificationChange"},{"id":"cg:sopChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/814507e0-e6cd-4bce-a4c6-4d1caa61cfc3_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2025-02-10T15:13:05.301Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/814507e0-e6cd-4bce-a4c6-4d1caa61cfc3_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2023-09-12T17:00:00.000Z","role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/814507e0-e6cd-4bce-a4c6-4d1caa61cfc3_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/814507e0-e6cd-4bce-a4c6-4d1caa61cfc3_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d03d2d1-943f-4821-b573-1eec255bf54c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2ae0707-3188-4190-ac47-ce4a9fbf05fc","type":"Finding","dc:description":"Expression gradually increased from embryonic day E11-E17, during the period of cerebral cortical neurogenesis. In situ hybridization analysis of E17 mice showed that there was slightly  more Arfgef2 mRNA in the cerebral cortical and diencephalic ventricular zones than in other CNS structures. Pattern of expression was consistent with a potential role in early neural precursor proliferation and neuronal migration.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14647276","rdfs:label":"Northern-blot analyses of whole-mouse Arfgef2 mRNA","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ad9cf19e-838e-4da1-a69a-73c29cc5c913","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2fca7b4-0275-49ed-98f4-74e3837008b3","type":"Finding","dc:description":"BIG2 and FLNA co-localization in neuroependymal progenitors; Immunohistochemistry conducted with double FLNA/BIG2 labeling on isolated neuroependymal progenitors from both mouse and human. The results demonstrated co-localization, inhibition of BIG2 inhibits transport of FLNA to the cell periphery. Inhibited BIG2 function in a human SHSY5Y neuroblastoma cell line and observed consequent changes in FLNA expression. Transfection using the dominant negative BIG2(E738K) construct demonstrated that FLNA appeared to be redistributed from the cell surface to the cell cytoplasm. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16320251","rdfs:label":"Inhibition of BIG2 inhibits transport of FLNA","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2d332d08-f86b-4340-9a69-efbe5a0fccf1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/093f128b-e8a3-4ef1-9414-7a4e9a55d49c","type":"Finding","dc:description":"Neural stem cells derived from the subventricular zone (the region responsible for neural proliferation and initial migration into cortex) of adult mice). Next, cultured neural progenitors were treated with BFA, a fungal metabolite that specifically inhibits the Sec7 domains of the high molecular-weight (>200 kDa) ARFGEFs (BIG1 and BIG2 but not GBF1). The results demonstrated that inhibition of BIG1 and BIG2 by BFA specifically disrupts the Golgi complex and TGN with preservation of other cytoplasmic structures. Additionally, progenitors treated with BFA had less proliferation with no increase in cell death\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14647276","rdfs:label":"treatment of murine cultured neural progenitors with BFA","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b0304547-5004-4d15-bb87-2e5fa3302099","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c22cd6c1-4519-4f84-88e0-ab7c24eac25c","type":"Finding","dc:description":"Immunohistochemistry with double FLNA/BIG2 labeling on isolated neuroependymal progenitors from both mouse and human demonstrated co-localization\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16320251","rdfs:label":"BIG2 and FLNA co-localization in neuroependymal progenitors","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/814507e0-e6cd-4bce-a4c6-4d1caa61cfc3_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/546b6db0-6cc7-4dc7-95e1-5aacee4e3a5b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d655a68-427b-4013-8a12-99e2557898fa","type":"FunctionalAlteration","dc:description":"Proliferation of HEK293 cells was significantly less than that of cells expressing wild-type BIG2","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14647276","rdfs:label":"Dominant negative mutant BIG2 in HEK293 cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/814507e0-e6cd-4bce-a4c6-4d1caa61cfc3_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e97ff5ce-3b4d-497c-8173-69e72c286018_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e97ff5ce-3b4d-497c-8173-69e72c286018","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23755938","rdfs:label":"Proband 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/a8136733-7555-4aa7-a01b-34932bd212cc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006420.3(ARFGEF2):c.242_249del (p.Pro81ArgfsTer6)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695195962"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Failure to thrive, severe developmental delay, quadriplegia, axial hypotonia, feeding difficulties, vomiting, recurrent infections, slow background, paroxysmal theta activity, corticosubcortical, putamen increased signal intensity, obstructive cardiomyopathy","previousTesting":true,"previousTestingDescription":"A negative search for mutations in the X-linked FLNA gene ","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/608cc1f4-40b1-4022-9083-a6ccf9e768bf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23755938","allele":{"id":"https://genegraph.clinicalgenome.org/r/a8136733-7555-4aa7-a01b-34932bd212cc"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/608cc1f4-40b1-4022-9083-a6ccf9e768bf","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/608cc1f4-40b1-4022-9083-a6ccf9e768bf_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/a805c333-0f8e-4554-9dc0-cf0208b542bb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a805c333-0f8e-4554-9dc0-cf0208b542bb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14647276","rdfs:label":"Family 2 proband 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e829e23-d47e-4f03-a411-3eacd12726b9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006420.3(ARFGEF2):c.[242C>A;247_249delinsTT] (p.[Pro81Gln;Val83LeufsTer?])","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573318213"}},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"bilateral, continuous nodular heterotopia along the margin of the lateral ventricles and small cerebral cortex., prominent or enlarged ventricles, small corpus callosum, relative preservation of the cerebellum and brainstem","secondTestingMethod":"Linkage analysis","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7a621295-fcdf-4616-873f-9e6db2c0694d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14647276","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e829e23-d47e-4f03-a411-3eacd12726b9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/7a621295-fcdf-4616-873f-9e6db2c0694d","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a621295-fcdf-4616-873f-9e6db2c0694d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/84a03337-24fa-47f0-8169-7a93d42dcd09_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84a03337-24fa-47f0-8169-7a93d42dcd09","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26126837","rdfs:label":"Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/67e87f71-a2d7-4b4c-a2d5-19ed2d4e41de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006420.3(ARFGEF2):c.5126G>A (p.Trp1709Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA409339224"}},"detectionMethod":"Direct Sequencing ","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"severe developmental and growth delay, feeding problems, involuntary movements, bilateral periventricular nodular heterotopia, putaminal hyperintensity, left ventricular non-compaction cardiomyopathy","secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b5d814c6-91ac-49c0-b911-4d8d3e09db60_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26126837","allele":{"id":"https://genegraph.clinicalgenome.org/r/67e87f71-a2d7-4b4c-a2d5-19ed2d4e41de"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/b5d814c6-91ac-49c0-b911-4d8d3e09db60","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5d814c6-91ac-49c0-b911-4d8d3e09db60_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/026e92d4-66f2-498d-8fda-0fd84cb84162_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/026e92d4-66f2-498d-8fda-0fd84cb84162","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14647276","rdfs:label":"Pedigree 1, individual 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/41b7d169-a3a7-4c5e-b530-acf871837bff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006420.3(ARFGEF2):c.625G>A (p.Glu209Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA213135"}},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"Microcephaly, feeding difficulties, severe ID, spastic quadriparesis, epilepsy, and periventricular nodular heterotopia.\n","secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3b15821d-1b21-4eeb-9d55-596d36aa1b4d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14647276","allele":{"id":"https://genegraph.clinicalgenome.org/r/41b7d169-a3a7-4c5e-b530-acf871837bff"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/3b15821d-1b21-4eeb-9d55-596d36aa1b4d","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b15821d-1b21-4eeb-9d55-596d36aa1b4d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/19e0d4ae-e1d9-439b-9e09-82224b3ed8c0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19e0d4ae-e1d9-439b-9e09-82224b3ed8c0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19384555","rdfs:label":"Proband 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/074998c4-ea79-4573-af1d-86dfecf270d2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006420.3(ARFGEF2):c.3798_3802del (p.Phe1267GlyfsTer17)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580617731"}},{"id":"https://genegraph.clinicalgenome.org/r/07b8a9ee-93ef-444b-823c-a2160e63278b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006420.3(ARFGEF2):c.2031_2038dup (p.Gln680ProfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580617730"}}],"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"feeding problems, severe drooling, frequent vomiting, dystonic-spastic paraplegia with axial hypotonia, seizures, no language, severe extrapyramidal movement disorder with irregular repetitive jerking movements, myelination delay, generalized atrophy","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b03a4f5c-d599-4776-aa95-679a74259cfa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19384555","allele":{"id":"https://genegraph.clinicalgenome.org/r/07b8a9ee-93ef-444b-823c-a2160e63278b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/522a0a95-7c92-48a7-957a-ebd76dae605e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19384555","allele":{"id":"https://genegraph.clinicalgenome.org/r/074998c4-ea79-4573-af1d-86dfecf270d2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/b03a4f5c-d599-4776-aa95-679a74259cfa","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b03a4f5c-d599-4776-aa95-679a74259cfa_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/522a0a95-7c92-48a7-957a-ebd76dae605e","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/522a0a95-7c92-48a7-957a-ebd76dae605e_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/814507e0-e6cd-4bce-a4c6-4d1caa61cfc3_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55cd6813-8356-4576-920c-dadae2b5f247_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23755938","rdfs:label":"Family 1","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/55cd6813-8356-4576-920c-dadae2b5f247","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/e97ff5ce-3b4d-497c-8173-69e72c286018"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e97ff5ce-3b4d-497c-8173-69e72c286018"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/4d1bfafe-8e4b-4fc6-8ee5-ff6a94146b6d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25160555","rdfs:label":"Family 1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/4d1bfafe-8e4b-4fc6-8ee5-ff6a94146b6d","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/db8f1802-ab54-40c2-85a0-f31f1f6d6943","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25160555","rdfs:label":"Proband 1","ageType":"AgeAtReport","ageUnit":"Months","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a928e4d8-d45a-4241-b64d-090ab4798962","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006420.3(ARFGEF2):c.388C>T (p.Gln130Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA409317535"}},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"microcephaly,  psychomotor delay by 6 months, axial hypotonia with a prominent dystonic-athetoid component,  asymmetric ventriculomegaly plus diffuse nodules lining the temporal horns, a thin corpus callosum, hyperintensity signal in putamens, no seizures.","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/af92156c-189e-4823-bd62-2654e1fc6cd1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25160555","allele":{"id":"https://genegraph.clinicalgenome.org/r/a928e4d8-d45a-4241-b64d-090ab4798962"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/db8f1802-ab54-40c2-85a0-f31f1f6d6943"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/f43a3484-0bd0-4859-a7ac-08ddefab192a_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 2 individuals are affected.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14647276","rdfs:label":"Family 2","estimatedLodScore":1.23,"family":{"id":"https://genegraph.clinicalgenome.org/r/f43a3484-0bd0-4859-a7ac-08ddefab192a","type":"Family","rdfs:label":"Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/a805c333-0f8e-4554-9dc0-cf0208b542bb"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":5,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a805c333-0f8e-4554-9dc0-cf0208b542bb"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/39f2dce6-6827-4b61-a4ea-33f43740dd17_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812912","rdfs:label":"Family 1","estimatedLodScore":2.06,"family":{"id":"https://genegraph.clinicalgenome.org/r/39f2dce6-6827-4b61-a4ea-33f43740dd17","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0805c5d1-6041-4d05-9f1b-d6f6bdcef12b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812912","rdfs:label":"Proband 1_1067","ageType":"AgeAtReport","ageUnit":"Months","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c7c5aeb2-e732-4205-bfda-35bd52df7964","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006420.3(ARFGEF2):c.1958+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA213194"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Hypsarrhythmic pattern on EEG, seizures, severe developmental delay, severe hypotonia","secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5d3071f8-4deb-419a-b2b9-821c5aef5a21_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23812912","allele":{"id":"https://genegraph.clinicalgenome.org/r/c7c5aeb2-e732-4205-bfda-35bd52df7964"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Hypsarrhythmic pattern on EEG, seizures, severe developmental delay, severe hypotonia","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/0805c5d1-6041-4d05-9f1b-d6f6bdcef12b"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/d1eb0553-e4f7-4de3-98b6-73ef9a21df0d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14647276","rdfs:label":"Family 1","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/d1eb0553-e4f7-4de3-98b6-73ef9a21df0d","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/026e92d4-66f2-498d-8fda-0fd84cb84162"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Microcephaly, feeding difficulties, severe ID, spastic quadriparesis, epilepsy, and periventricular nodular heterotopia.\n","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/026e92d4-66f2-498d-8fda-0fd84cb84162"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0805c5d1-6041-4d05-9f1b-d6f6bdcef12b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0805c5d1-6041-4d05-9f1b-d6f6bdcef12b"},{"id":"https://genegraph.clinicalgenome.org/r/5d3071f8-4deb-419a-b2b9-821c5aef5a21","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d3071f8-4deb-419a-b2b9-821c5aef5a21_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/db8f1802-ab54-40c2-85a0-f31f1f6d6943_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db8f1802-ab54-40c2-85a0-f31f1f6d6943"},{"id":"https://genegraph.clinicalgenome.org/r/af92156c-189e-4823-bd62-2654e1fc6cd1","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/af92156c-189e-4823-bd62-2654e1fc6cd1_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9951,"specifiedBy":"GeneValidityCriteria9","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/JnVjYyBk0uI","type":"GeneValidityProposition","disease":"obo:MONDO_0011966","gene":"hgnc:15853","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_814507e0-e6cd-4bce-a4c6-4d1caa61cfc3-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}